Vor Biopharma Inc (VOR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.19B
Last updated: Nov 17, 2026 at 11:05 AM ET
Vor Biopharma Inc (VOR) Earnings: Report Dates and Results
Vor Biopharma (VOR) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Vor Biopharma reported EPS of -$0.90, below the -$0.81 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
VOR has an expected report date of Mar 29, 2027.
Earnings History
Of the 22 quarters below that had an estimate, VOR beat 8, missed 13 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 43.46% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.90 | -$0.81 | N/A | -11.11% | Miss | N/A | 1 | 1 up, 1 down | Oct 30, 2026 |
| Jun 30, 2026 | -$0.80 | -$0.69 | -$0.82 - -$0.59 | -15.94% | Miss | N/A | 2 | 1 up, 2 down | Aug 11, 2026 |
| Mar 31, 2026 | -$0.73 | -$0.78 | -$0.88 - -$0.69 | +6.41% | Beat | N/A | 4 | 3 up, 0 down | May 13, 2026 |
| Dec 31, 2025 | $307.53 | -$1.19 | -$1.90 - -$0.44 | N/A | N/A | N/A | 6 | N/A | Mar 30, 2026 |
| Sep 30, 2025 | -$121.63 | -$4.10 | -$4.22 - -$3.98 | N/A | N/A | N/A | 2 | 0 up, 0 down | Nov 13, 2025 |
| Jun 30, 2025 | -$251.20 | -$236.00 | N/A | -6.44% | Miss | N/A | 3 | 0 up, 1 down | Aug 12, 2025 |
| Mar 31, 2025 | -$5.20 | -$4.16 | -$5.00 - -$2.60 | -25.00% | Miss | N/A | 5 | 2 up, 1 down | May 14, 2025 |
| Dec 31, 2024 | -$0.44 | -$0.31 | -$0.36 - -$0.20 | -43.46% | Miss | N/A | 6 | 0 up, 0 down | Mar 20, 2025 |
| Sep 30, 2024 | -$8.00 | -$8.00 | -$8.80 - -$7.20 | 0.00% | In line | N/A | 9 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$8.20 | -$8.29 | -$9.40 - -$7.20 | +1.09% | Beat | N/A | 9 | 0 up, 0 down | Aug 8, 2024 |
| Mar 31, 2024 | -$9.00 | -$7.63 | -$8.40 - -$6.80 | -17.96% | Miss | N/A | 9 | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$0.39 | -$0.50 | -$0.53 - -$0.46 | +22.00% | Beat | N/A | 9 | 0 up, 0 down | Mar 20, 2024 |
| Sep 30, 2023 | -$9.80 | -$9.17 | -$9.80 - -$8.60 | -6.87% | Miss | N/A | 9 | 0 up, 0 down | Nov 7, 2023 |
| Jun 30, 2023 | -$9.00 | -$8.46 | -$9.20 - -$7.80 | -6.38% | Miss | N/A | 9 | 0 up, 0 down | Aug 10, 2023 |
| Mar 31, 2023 | -$8.60 | -$7.77 | -$8.40 - -$7.20 | -10.68% | Miss | N/A | 8 | 0 up, 0 down | May 11, 2023 |
| Dec 31, 2022 | -$0.52 | -$0.60 | -$0.81 - -$0.38 | +13.33% | Beat | N/A | 8 | 0 up, 0 down | Mar 23, 2023 |
| Sep 30, 2022 | -$12.60 | -$11.89 | -$14.00 - -$11.40 | -5.97% | Miss | N/A | 8 | 0 up, 0 down | Nov 10, 2022 |
| Jun 30, 2022 | -$11.60 | -$13.00 | N/A | +10.77% | Beat | N/A | N/A | 0 up, 0 down | Aug 11, 2022 |
| Mar 31, 2022 | -$12.20 | -$10.29 | -$11.60 - -$8.60 | -18.56% | Miss | N/A | 7 | 0 up, 0 down | May 12, 2022 |
| Dec 31, 2021 | -$0.48 | -$0.57 | -$0.74 - -$0.51 | +15.79% | Beat | N/A | 7 | 0 up, 0 down | Mar 14, 2022 |
| Sep 30, 2021 | -$10.00 | -$11.50 | -$16.80 - -$10.20 | +13.04% | Beat | N/A | 4 | 0 up, 0 down | Nov 10, 2021 |
| Jun 30, 2021 | -$10.00 | -$9.27 | -$11.80 - -$7.60 | -7.87% | Miss | N/A | 4 | N/A | Aug 9, 2021 |
| Mar 31, 2021 | -$13.40 | -$15.20 | -$16.20 - -$8.60 | +11.84% | Beat | N/A | 3 | N/A | May 6, 2021 |
| Dec 31, 2020 | -$217.49 | -$4.40 | N/A | N/A | N/A | N/A | 2 | N/A | Mar 25, 2021 |
| Sep 30, 2020 | -$7.26 | -$5.33 | N/A | -36.21% | Miss | N/A | N/A | N/A | Dec 18, 2020 |
| Jun 30, 2020 | -$4.67 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 |
| Mar 31, 2020 | -$4.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2020 |
| Dec 31, 2019 | -$4.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 |
| Jun 30, 2019 | -$2.62 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2019 |
| Mar 31, 2019 | -$1.33 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2019 |
| Dec 31, 2018 | -$1.33 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2019 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$70.50, after -$25.64 the year before. It was -$1.33 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$70.50 | N/A |
| Dec 31, 2024 | -$25.64 | N/A |
| Dec 31, 2023 | -$27.79 | N/A |
| Dec 31, 2022 | -$36.92 | N/A |
| Dec 31, 2021 | -$33.88 | N/A |
| Dec 31, 2020 | -$233.56 | N/A |
| Dec 31, 2019 | -$8.08 | N/A |
| Dec 31, 2018 | -$1.33 | N/A |
Frequently Asked Questions About VOR
When is Vor Biopharma's next earnings date?
Vor Biopharma's next earnings report is expected for Mar 29, 2027.
Did VOR beat earnings estimates last quarter?
No. Vor Biopharma reported EPS of -$0.90 for the quarter ended Sep 30, 2026, below the -$0.81 estimate by 11.11%.
What EPS do analysts expect from VOR next quarter?
The consensus EPS estimate for Vor Biopharma for the quarter ending Dec 31, 2026 is -$0.95 from 11 analysts, with estimates from -$1.17 to -$0.78.
How often does VOR beat earnings estimates?
Vor Biopharma beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -11.81%.
VOR pages: Overview, Earnings, Forecast, Financials, Competitors